206 related articles for article (PubMed ID: 33639258)
1. Synaptic density in healthy human aging is not influenced by age or sex: a
Michiels L; Delva A; van Aalst J; Ceccarini J; Vandenberghe W; Vandenbulcke M; Koole M; Lemmens R; Laere KV
Neuroimage; 2021 May; 232():117877. PubMed ID: 33639258
[TBL] [Abstract][Full Text] [Related]
2. Reduced synaptic vesicle protein 2A binding in temporal lobe epilepsy: A [
Finnema SJ; Toyonaga T; Detyniecki K; Chen MK; Dias M; Wang Q; Lin SF; Naganawa M; Gallezot JD; Lu Y; Nabulsi NB; Huang Y; Spencer DD; Carson RE
Epilepsia; 2020 Oct; 61(10):2183-2193. PubMed ID: 32944949
[TBL] [Abstract][Full Text] [Related]
3. Healthy brain aging assessed with [
Andersen KB; Hansen AK; Knudsen K; Schacht AC; Damholdt MF; Brooks DJ; Borghammer P
Nucl Med Biol; 2022; 112-113():52-58. PubMed ID: 35820300
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal Synaptic Density PET with
Michiels L; Thijs L; Mertens N; Coremans M; Vandenbulcke M; Verheyden G; Koole M; Van Laere K; Lemmens R
Ann Neurol; 2023 May; 93(5):911-921. PubMed ID: 36585914
[TBL] [Abstract][Full Text] [Related]
5. Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging.
Chen MK; Mecca AP; Naganawa M; Finnema SJ; Toyonaga T; Lin SF; Najafzadeh S; Ropchan J; Lu Y; McDonald JW; Michalak HR; Nabulsi NB; Arnsten AFT; Huang Y; Carson RE; van Dyck CH
JAMA Neurol; 2018 Oct; 75(10):1215-1224. PubMed ID: 30014145
[TBL] [Abstract][Full Text] [Related]
6. First-in-Human Evaluation of
Naganawa M; Li S; Nabulsi N; Henry S; Zheng MQ; Pracitto R; Cai Z; Gao H; Kapinos M; Labaree D; Matuskey D; Huang Y; Carson RE
J Nucl Med; 2021 Apr; 62(4):561-567. PubMed ID: 32859701
[TBL] [Abstract][Full Text] [Related]
7. In vivo imaging of synaptic density with [
Xiong M; Roshanbin S; Rokka J; Schlein E; Ingelsson M; Sehlin D; Eriksson J; Syvänen S
Neuroimage; 2021 Oct; 239():118302. PubMed ID: 34174391
[TBL] [Abstract][Full Text] [Related]
8. The regional pattern of age-related synaptic loss in the human brain differs from gray matter volume loss: in vivo PET measurement with [
Toyonaga T; Khattar N; Wu Y; Lu Y; Naganawa M; Gallezot JD; Matuskey D; Mecca AP; Pittman B; Dias M; Nabulsi NB; Finnema SJ; Chen MK; Arnsten A; Radhakrishnan R; Skosnik PD; D'Souza DC; Esterlis I; Huang Y; van Dyck CH; Carson RE
Eur J Nucl Med Mol Imaging; 2024 Mar; 51(4):1012-1022. PubMed ID: 37955791
[TBL] [Abstract][Full Text] [Related]
9. Preclinical PET Studies of [
Thomsen MB; Schacht AC; Alstrup AKO; Jacobsen J; Lillethorup TP; Bærentzen SL; Noer O; Orlowski D; Elfving B; Müller HK; Brooks DJ; Landau AM
Mol Imaging Biol; 2020 Oct; 22(5):1290-1300. PubMed ID: 32514885
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Preclinical Evaluation of 11C-UCB-J as a PET Tracer for Imaging the Synaptic Vesicle Glycoprotein 2A in the Brain.
Nabulsi NB; Mercier J; Holden D; Carré S; Najafzadeh S; Vandergeten MC; Lin SF; Deo A; Price N; Wood M; Lara-Jaime T; Montel F; Laruelle M; Carson RE; Hannestad J; Huang Y
J Nucl Med; 2016 May; 57(5):777-84. PubMed ID: 26848175
[TBL] [Abstract][Full Text] [Related]
11. Synaptic Damage and Its Clinical Correlates in People With Early Huntington Disease: A PET Study.
Delva A; Michiels L; Koole M; Van Laere K; Vandenberghe W
Neurology; 2022 Jan; 98(1):e83-e94. PubMed ID: 34663644
[TBL] [Abstract][Full Text] [Related]
12. Validation of Parametric Methods for [
Mertens N; Maguire RP; Serdons K; Lacroix B; Mercier J; Sciberras D; Van Laere K; Koole M
Mol Imaging Biol; 2020 Apr; 22(2):444-452. PubMed ID: 31209780
[TBL] [Abstract][Full Text] [Related]
13. Changes in synaptic density in the subacute phase after ischemic stroke: A
Michiels L; Mertens N; Thijs L; Radwan A; Sunaert S; Vandenbulcke M; Verheyden G; Koole M; Van Laere K; Lemmens R
J Cereb Blood Flow Metab; 2022 Feb; 42(2):303-314. PubMed ID: 34550834
[TBL] [Abstract][Full Text] [Related]
14. Identifying brain networks in synaptic density PET (
Fang XT; Toyonaga T; Hillmer AT; Matuskey D; Holmes SE; Radhakrishnan R; Mecca AP; van Dyck CH; D'Souza DC; Esterlis I; Worhunsky PD; Carson RE
Neuroimage; 2021 Aug; 237():118167. PubMed ID: 34000404
[TBL] [Abstract][Full Text] [Related]
15. Autoradiographic mapping of synaptic vesicle glycoprotein 2A in non-human primate and human brain.
Varnäs K; Stepanov V; Halldin C
Synapse; 2020 Oct; 74(10):e22157. PubMed ID: 32259300
[TBL] [Abstract][Full Text] [Related]
16. Reduced Synaptic Density in Patients with Lewy Body Dementia: An [
Andersen KB; Hansen AK; Damholdt MF; Horsager J; Skjaerbaek C; Gottrup H; Klit H; Schacht AC; Danielsen EH; Brooks DJ; Borghammer P
Mov Disord; 2021 Sep; 36(9):2057-2065. PubMed ID: 33899255
[TBL] [Abstract][Full Text] [Related]
17. Kinetic evaluation and test-retest reproducibility of [
Finnema SJ; Nabulsi NB; Mercier J; Lin SF; Chen MK; Matuskey D; Gallezot JD; Henry S; Hannestad J; Huang Y; Carson RE
J Cereb Blood Flow Metab; 2018 Nov; 38(11):2041-2052. PubMed ID: 28792356
[TBL] [Abstract][Full Text] [Related]
18. Development and In Vivo Preclinical Imaging of Fluorine-18-Labeled Synaptic Vesicle Protein 2A (SV2A) PET Tracers.
Constantinescu CC; Tresse C; Zheng M; Gouasmat A; Carroll VM; Mistico L; Alagille D; Sandiego CM; Papin C; Marek K; Seibyl JP; Tamagnan GD; Barret O
Mol Imaging Biol; 2019 Jun; 21(3):509-518. PubMed ID: 30084043
[TBL] [Abstract][Full Text] [Related]
19. Mild Motor Signs in Healthy Aging Are Associated with Lower Synaptic Density in the Brain.
Van Cauwenberge MGA; Delva A; Vande Casteele T; Laroy M; Radwan A; Vansteelandt K; Van den Stock J; Bouckaert F; Van Laere K; Emsell L; Vandenberghe W; Vandenbulcke M
Mov Disord; 2023 Oct; 38(10):1786-1794. PubMed ID: 37574924
[TBL] [Abstract][Full Text] [Related]
20. Quantifying SV2A density and drug occupancy in the human brain using [
Koole M; van Aalst J; Devrome M; Mertens N; Serdons K; Lacroix B; Mercier J; Sciberras D; Maguire P; Van Laere K
Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):396-406. PubMed ID: 30121895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
